ADAD (Huaizhong Health Group) EBITDA Margin %: 0.00% (As of Jan. 2023)


ADAD Huaizhong Health Group Inc ADAD
34 GF Score
Price $0.00
View Full Analysis

What is Huaizhong Health Group EBITDA Margin %?

Huaizhong Health Group ADAD 34 EBITDA Margin % is 0.00% as of Jan. 2023. GuruFocus rates ADAD with a GF Score™ of 34/100.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Huaizhong Health Group's EBITDA for the three months ended in Jan. 2023 was $-0.01 Mil. Huaizhong Health Group's Revenue for the three months ended in Jan. 2023 was $0.00 Mil. Therefore, Huaizhong Health Group's EBITDA margin for the quarter that ended in Jan. 2023 was 0.00%.

Huaizhong Health Group  (OTCPK:ADAD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Huaizhong Health Group EBITDA Margin % Related Terms

Huaizhong Health Group EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Huaizhong Health Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Huaizhong Health Group EBITDA Margin % Chart

Huaizhong Health Group Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.76 0.00 0.00 0.00 0.00

Huaizhong Health Group Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ADAD vs AMRR, NLSC, CLOW: EBITDA Margin % Comparison

For the Shell Companies subindustry, Huaizhong Health Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Huaizhong Health Group EBITDA Margin % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Huaizhong Health Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Huaizhong Health Group's EBITDA Margin % falls into.


ADAD
34GF Score
Huaizhong Health Group Inc ADAD
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Huaizhong Health Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Huaizhong Health Group's EBITDA Margin % for the fiscal year that ended in Oct. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2022 )/Revenue (A: Oct. 2022 )
=-0.029/0
= %

Huaizhong Health Group's EBITDA Margin % for the quarter that ended in Jan. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Jan. 2023 )/Revenue (Q: Jan. 2023 )
=-0.011/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
Huaizhong Health Group (ADAD) has a EBITDA Margin % of 0.00% as of Jan. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Huaizhong Health Group and its competitors.
Is Huaizhong Health Group's EBITDA Margin % too high?
Huaizhong Health Group's current EBITDA Margin % is 0.00%. Overall, Huaizhong Health Group has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Huaizhong Health Group's EBITDA Margin % compare to AMRR and NLSC?
Huaizhong Health Group's EBITDA Margin % of 0.00% can be compared against companies in the Diversified Financial Services industry. The industry median EBITDA Margin % is 11.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Diversified Financial Services company?
The median EBITDA Margin % among Diversified Financial Services companies is 11.75, based on 93 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Huaizhong Health Group and its competitors. For the Diversified Financial Services industry, the median EBITDA Margin % is 11.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huaizhong Health Group's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huaizhong Health Group stock overvalued right now?
Huaizhong Health Group (ADAD) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Huaizhong Health Group's overall GF Score™ is 34/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Huaizhong Health Group (ADAD), the current EBITDA Margin % is 0.00% as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Huaizhong Health Group Business Description

Address 555 Panyu North Avenue, 13th Floor, Headquarters Center Building 16, Tianan Technology Park, Panyu District, Guangzhou, CHN, 523857
Huaizhong Health Group Inc is a shell company. It is, however, seeking to identify, locate, and, if warranted, acquire new commercial opportunities.
34GF Score

Get the complete analysis for ADAD

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price